Cabaletta Bio

Contributing Author

Recent Articles by Cabaletta Bio

Feb-05	Cabaletta Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 CABA -7.17% GlobeNewswire
Jan-12	Cabaletta Bio Announces 2026 Strategic Priorities CABA +5.24% GlobeNewswire
Nov-10	Cabaletta Bio Reports Third Quarter 2025 Financial Results and Provides Business Update CABA GlobeNewswire
Nov-04	Cabaletta Bio to Participate in Upcoming Investor Conferences in November and December CABA -10.30% GlobeNewswire
Oct-27	Cabaletta Bio Presents Positive Clinical Data and Development Updates for Rese-cel at ACR Convergence 2025 CABA +12.96% GlobeNewswire
Oct-14	Cabaletta Bio Announces Appointment of Steve Gavel as Chief Commercial Officer and Award of Inducement Grant CABA +16.06% GlobeNewswire
Oct-09	Cabaletta Bio Presents First Rese-cel Data with No Preconditioning Demonstrating Biologic Activity and Early Clinical Responses at the 2025 ESGCT Annual Congress CABA -18.60% CABA +18.26% GlobeNewswire
Aug-27	Cabaletta Bio to Participate in Upcoming Investor Conferences in September CABA GlobeNewswire
Aug-07	Cabaletta Bio Reports Second Quarter 2025 Financial Results and Provides Business Update CABA GlobeNewswire
Jun-11	Cabaletta Bio Announces Pricing of Public Offering of Securities CABA -25.53% GlobeNewswire
Jun-11	Cabaletta Bio Announces Proposed Public Offering of Securities CABA -25.53% GlobeNewswire
Jun-11	Cabaletta Bio Announces New Rese-cel Safety and Efficacy Data in Patients with Myositis, Lupus and Scleroderma to Be Presented at the EULAR 2025 Congress CABA -25.53% GlobeNewswire
May-29	Cabaletta Bio to Participate in the Jefferies Global Healthcare Conference CABA GlobeNewswire
May-15	Cabaletta Bio Announces 2027 Rese-cel BLA Submission Anticipated in Myositis Following Recent FDA Alignment on Registrational Cohorts CABA +39.23% GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved.